Open an account

KORU Medical Systems

KRMD · NASDAQ

$3.04+$0.02 (+0.66%)TodayMarket closed ·
Prev close $3.02

About KRMD

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Employees
73
Headquarters
Mahwah, New Jersey
Listed
Oct 27, 1993
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
korumedical.com

KRMD key statistics

Market cap
140.36M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
267.19K
Volume
108.37K
Open price
$3.04
High today
$3.09
Low today
$2.98
52 Week high
$6.61
52 Week low
$2.86

KORU Medical Systems (KRMD) at a glance

As of Oct 20, 2026, KORU Medical Systems (KRMD) shares are priced at $3.04, giving the company a market cap of 140.36M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.98 and $3.09. The current price is 2.0% above the day's low and 1.6% below its high.

Volume so far is 108.37K shares, below the average of 267.19K shares a day.

Over the past year KORU Medical Systems has ranged from $2.86 to $6.61, and now sits 5% of the way up that range.

KORU Medical Systems met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.013 per share against an estimate of -$0.0184.

The average analyst price target is $6.38, 109.7% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $6.38
Low
$5.05
Now
$3.04
High
$8.40

KRMD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 50.5% on average.

  1. Q3 FY24: reported -$0.03 per share against an estimate of -$0.0388
  2. Q4 FY24: reported -$0.03 per share against an estimate of -$0.0312
  3. Q1 FY25: reported -$0.02 per share against an estimate of -$0.0265
  4. Q2 FY25: reported $0.00 per share against an estimate of -$0.0224
  5. Q3 FY25: reported -$0.02 per share against an estimate of -$0.0286
  6. Q4 FY25: reported -$0.01 per share against an estimate of -$0.0202
  7. Q1 FY26: reported -$0.02 per share against an estimate of -$0.0204
  8. Q2 FY26: reported $0.013 per share against an estimate of -$0.0184

KRMD news

  • Press releaseBusiness Wire

    KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026

  • Press releaseBusiness Wire

    KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance

  • Press releaseBusiness Wire

    KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference

  • Press releaseBusiness Wire

    Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm

  • Press releaseBusiness Wire

    KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026

  • Press releaseBusiness Wire

    KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

  • Press releaseBusiness Wire

    KORU Medical Systems Announces First Quarter 2026 Results

  • Press releaseBusiness Wire

    KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026

Similar companies

Companies in the same industry as KORU Medical Systems

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.